Evidence map›Paper›PMID 34386545›Full record

ArticleOpen forum infectious diseases2021

Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant

L Meng, S Pourali, M M Hitchcock, D R Ha, E Mui, W Alegria, E Fox, C Diep, R Swayngim, A Chang and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06238297 (Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of Pneumonia), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06238297 narecruitingnot on this mapstarted 2024, after this paper: background citation

Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of Pneumonia (SNAP Study)

TypeinterventionalSponsorUniversity of Bari Aldo MoroRan2024 to 2025Enrolled76ConditionsPneumonia, BacterialArmsMRSA nasal swab based de-escalation
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Observational
  2. Impact of Methicillin-ResistantOpen forum infectious diseases · 2026
    Article
  3. Article
  4. KY-MRSA: a comprehensive review of methicillin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  5. Assessing the Predictive Value of Methicillin-ResistantOpen forum infectious diseases · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

L MengDepartment of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA.ORCID https://orcid.org/0000-0002-6874-7798
S PouraliDepartment of Pharmacy, Stanford Health Care, Stanford, California, USA.
M M HitchcockDivision of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
D R HaDepartment of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA.
E MuiDepartment of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA.
W AlegriaDepartment of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA.
E FoxDepartment of Pharmacy, Stanford Health Care, Stanford, California, USA.
C DiepDepartment of Pharmacy, Stanford Health Care, Stanford, California, USA.
R SwayngimDepartment of Pharmacy, Stanford Health Care, Stanford, California, USA.
A ChangDepartment of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA.
N BanaeiDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
S DeresinskiDepartment of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA.
M HolubarDepartment of Quality, Patient Safety and Effectiveness, Stanford Health Care, Stanford, California, USA.ORCID https://orcid.org/0000-0002-7585-1809

Funding

EMERGING INFECTIOUS DISEASEST32AI007502 · NIAID · STANFORD UNIVERSITY · PI Prasanna Jagannathan, DAVID A. RELMAN · 1995 to 2026
$6.8M
Global Epidemiology of Infectious DiseasesT32AI052073 · NIAID · STANFORD UNIVERSITY · PI Angelle Desiree LaBeaud, Stephen Patrick Luby · 2003 to 2026
$4.2M
NIAID NIH HHS T32 AI007502NIAID NIH HHS T32 AI052073
6 · The paper itself

Abstract

A pharmacist-driven methicillin-resistant

Indexed as

MRSApneumoniarapid diagnosticsstewardshipvancomycin

Identifiers

PMID34386545
PMCPMC8355456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.